According to research, FCM causes an acute increase in blood levels of physiologically active fibroblast growth factor 23, which in turn causes a rise in urine phosphate excretion and a decrease in serum levels of 1,25-dihydroxyvitamin D, leading to a high prevalence of hypophosphatemia [37,38]. The gene discussed is FGF23; the disease is hypophosphatemia.